1-Acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles: Exhibiting anticancer activity through intracellular ROS scavenging and the mitochondria-dependent death pathway
dc.contributor.author | Alex, Jimi M. | |
dc.contributor.author | Singh, Sandeep | |
dc.contributor.author | Kumar, Raj | |
dc.date.accessioned | 2017-08-03T09:19:13Z | |
dc.date.accessioned | 2024-08-13T12:05:45Z | |
dc.date.available | 2017-08-03T09:19:13Z | |
dc.date.available | 2024-08-13T12:05:45Z | |
dc.date.issued | 2014 | |
dc.date.issued | 2014 | |
dc.description.abstract | A series of 17 analogs of 1-acetyl-4,5-dihydro(1H)pyrazoles (JP-1 to JP-17) bearing two aromatic rings at positions 3 and 5, either of which ought to be heterocyclic, were synthesized and evaluated for their anti-proliferative potential against breast cancer (MCF-7 and T-47D) and lung cancer (H-460 and A-549) cell lines for the first time. JP-1-7, -10, -11, -14, and -15 were observed to exhibit significant anti-proliferative activity against MCF-7 cells. Some notions about structure-activity relationships are reported. The investigated compounds were found to lower the intracellular reactive oxygen species in the H2DCFDA assay and also caused mitochondria-dependent cell death in the MCF-7 cell line, indicating a plausible mechanism of their anticancer effect. Analogs of 1-acetyl-4,5-dihydro(1H)pyrazoles (JP-1-17) were synthesized and evaluated for their anti-proliferative activity in four cancer cell lines and for their intracellular ROS scavenging properties. An attempt was made to determine the mitochondrial membrane potential of MCF-7 cells treated with JP-1 and -14, aiming to elucidate the mechanism by which proliferation was curbed. ? 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. | en_US |
dc.identifier.citation | Alex, J. M., Singh, S., & Kumar, R. (2014). 1-Acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles: Exhibiting anticancer activity through intracellular ROS scavenging and the mitochondria-dependent death pathway. Archiv Der Pharmazie, 347(10), 717-727. doi: 10.1002/ardp.201400199 | en_US |
dc.identifier.doi | 10.1002/ardp.201400199 | |
dc.identifier.issn | Print- 0365-6233 | |
dc.identifier.issn | Online- 1521-4184 | |
dc.identifier.issn | 3656233 | |
dc.identifier.uri | https://kr.cup.edu.in/handle/32116/279 | |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/abs/10.1002/ardp.201400199 | |
dc.language.iso | en | en_US |
dc.publisher | Wiley-VCH Verlag | en_US |
dc.subject | 1 acetyl 3,5 diaryl 4,5 dihydro(1h)pyrazole derivative | en_US |
dc.subject | 1 [3 (2,4 dichlorophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone | en_US |
dc.subject | 1 [3 (2,4 dichlorophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone | en_US |
dc.subject | 1 [3 (4 bromophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone | en_US |
dc.subject | 1 [3 (4 bromophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone | en_US |
dc.subject | 1 [3 (4 chlorophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone | en_US |
dc.subject | 1 [3 (4 chlorophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)py | en_US |
dc.title | 1-Acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles: Exhibiting anticancer activity through intracellular ROS scavenging and the mitochondria-dependent death pathway | en_US |
dc.title.journal | Archiv der Pharmazie | |
dc.type | Article | en_US |